Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on: September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on:September 27,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in

Updated on: November 09,2024

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in

Updated on:November 09,2024

ACO enrollment ups appropriateness of CA screening

(HealthDay)—Enrollment in the Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) is associated with a reduction in breast cancer screening and an increase in colorectal cancer

Updated on: March 27,2024

ACO enrollment ups appropriateness of CA screening

(HealthDay)—Enrollment in the Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) is associated with a reduction in breast cancer screening and an increase in colorectal cancer

Updated on:March 27,2024

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur

Updated on: January 23,2024

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur

Updated on:January 23,2024

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress

Updated on: May 09,2024

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress

Updated on:May 09,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on: January 29,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on:January 29,2024

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on: June 04,2024

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on:June 04,2024

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen

Updated on: June 22,2024

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen

Updated on:June 22,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on: April 01,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on:April 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on: April 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on:April 01,2024